Showing 1 - 5 results of 5 for search 'Sophie E. M. Veldhuijzen van Zanten', query time: 0.04s Refine Results
  1. 1
    Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners

    Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners by Yulun Wu, Tobias C. Wood, Sophie H. A. E. Derks, Ilanah J. Pruis, Sebastian van der Voort, Sophie E. M. Veldhuijzen van Zanten, Marion Smits, Esther A. H. Warnert

    Published 2023-10-01
    Get full text
    Article
  2. 2
    FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances

    FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances by Sophie E. M. Veldhuijzen van Zanten, Kay J. Pieterman, Bas P. L. Wijnhoven, Ilanah J. Pruis, Bas Groot Koerkamp, Lydi M. J. W. van Driel, Frederik A. Verburg, Maarten G. J. Thomeer

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging studyResearch in context

    Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label,... by Ilanah J. Pruis, Pieter Jan van Doormaal, Rutger K. Balvers, Martin J. van den Bent, Anita A. Harteveld, Linda C. de Jong, Mark W. Konijnenberg, Marcel Segbers, Roelf Valkema, Frederik A. Verburg, Marion Smits, Sophie E.M. Veldhuijzen van Zanten

    Published 2024-04-01
    Get full text
    Article
  4. 4
    Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors

    Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors by Dennis S. Metselaar, Michaël H. Meel, Joshua R. Goulding, Aimeé du Chatinier, Leyla Rigamonti, Piotr Waranecki, Neal Geisemeyer, Mark C. de Gooijer, Marjolein Breur, Jan Koster, Sophie E.M. Veldhuijzen van Zanten, Marianna Bugiani, Niels E. Franke, Alyssa Reddy, Pieter Wesseling, Gertjan J.L. Kaspers, Esther Hulleman

    Published 2024-09-01
    Get full text
    Article
  5. 5
    The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study

    The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study by Marie R. Vermeiren, Joost Somsen, Gert Luurtsema, Fransje E. Reesink, Nicolaas A. Verwey, Liesbeth Hempenius, Nelleke Tolboom, Geert Jan Biessels, J. Matthijs Biesbroek, Meike W. Vernooij, Sophie E. M. Veldhuijzen van Zanten, Harro Seelaar, Emma M. Coomans, Charlotte E. Teunissen, Afina W. Lemstra, Argonde C. van Harten, Leonie N. C. Visser, Wiesje M. van der Flier, Elsmarieke van de Giessen, Rik Ossenkoppele

    Published 2024-10-01
    Get full text
    Article

Search Tools: